(Q42706056)

English

Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways

scientific article published on 7 May 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

reperfusion injury

1 reference

based on heuristic

inferred from title

cerebral infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

X Meng

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

M Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

X Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

G Sun

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

J Ye

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

H Xu

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

X Sun

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Free Radical Research

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

823-838

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Primary prevention of ischemic stroke

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

1,026 experimental treatments in acute stroke

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

The 1027th target candidate in stroke: Will NADPH oxidase hold up?

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

The science of stroke: mechanisms in search of treatments

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Neuropathological alterations in Alzheimer disease

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Intranasal ginsenoside Rb1 targets the brain and ameliorates cerebral ischemia/reperfusion injury in rats

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Notoginsenoside R1 from Panax notoginseng inhibits TNF-alpha-induced PAI-1 production in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: a novel mechanism of Nrf2/ARE signaling activation

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Protocol for middle cerebral artery occlusion by an intraluminal suture method

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Assessment of heme oxygenase-1 (HO-1) activity in the cavernous tissues of sildenafil citrate-treated rats

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abeta-induced cytotoxicity in PC12 cells

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Apoptosis: a review of programmed cell death

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Reactive oxygen species and ischemic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

NOX1, 2, 4, 5: counting out oxidative stress

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Phytoestrogens: recent developments.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2014.911853

21 January 2018

Identifiers

10.3109/10715762.2014.911853

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42706056&oldid=1966372369"